A wild guess [Surveys]

posted by ElMaestro  – Denmark, 2014-10-24 00:47 (4252 d 15:06 ago) – Posting: # 13784
Views: 14,189

Hi Hötzi,

A wild guess: I think you are fiddling around with WHO Technical Report Series, No. 937, annex 7 (Multisource BlahDeeBlah),
specifically you might be looking at section 6.3.2: "If the bioequivalence study was performed with the appropriate number of subjects but bioequivalence cannot be demonstrated because of a larger than expected random variation or a relative difference, an add-on subject study can be performed using not less than half the number of subjects in the initial study, provided this eventuality was anticipated and provided for in the study protocol."
as well as 6.11.3: "the total sample size of the initial bioequivalence study is not less than 20 (n = 10/group) or pooled sample size of the initial and add-on subject studies is not less than 30;"

-which lend from the PMDA guidelines section 2.5.
In a nutshell you are trying to figure out how the overall alpha behaves for various scenarios, incl. adjusted alphas, anticipated to comply with the Japanese add-on recommendations.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
129 visitors (0 registered, 129 guests [including 19 identified bots]).
Forum time: 15:54 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5